Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54


Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax.

Tournier JN, Rougeaux C, Biot FV, Goossens PL.

mSphere. 2019 Jun 19;4(3). pii: e00282-19. doi: 10.1128/mSphere.00282-19.


Corrigendum: Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections.

El-Aouar Filho RA, Nicolas A, De Paula Castro TL, Deplanche M, De Carvalho Azevedo VA, Goossens PL, Taieb F, Lina G, Le Loir Y, Berkova N.

Front Cell Infect Microbiol. 2017 Aug 14;7:364. doi: 10.3389/fcimb.2017.00364. eCollection 2017.


Effect of replacing main-chain ureas with thiourea and guanidinium surrogates on the bactericidal activity of membrane active oligourea foldamers.

Antunes S, Corre JP, Mikaty G, Douat C, Goossens PL, Guichard G.

Bioorg Med Chem. 2017 Aug 15;25(16):4245-4252. doi: 10.1016/j.bmc.2017.04.040. Epub 2017 Apr 29.


[iNKT cells: potential therapeutic targets to fight anthrax].

Le Gars M, Haustant M, Klezovich-Benard M, Paget C, Trottein F, Goossens PL, Tournier JN.

Med Sci (Paris). 2017 May;33(5):488-490. doi: 10.1051/medsci/20173305010. Epub 2017 Jun 14. French. No abstract available.


Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections.

El-Aouar Filho RA, Nicolas A, De Paula Castro TL, Deplanche M, De Carvalho Azevedo VA, Goossens PL, Taieb F, Lina G, Le Loir Y, Berkova N.

Front Cell Infect Microbiol. 2017 May 23;7:208. doi: 10.3389/fcimb.2017.00208. eCollection 2017. Review. Erratum in: Front Cell Infect Microbiol. 2017 Aug 14;7:364.


Corrigendum: In vivo dynamics of active edema and lethal factors during anthrax.

Rougeaux C, Becher F, Ezan E, Tournier JN, Goossens PL.

Sci Rep. 2017 Feb 13;7:39579. doi: 10.1038/srep39579. No abstract available.


Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination.

Le Gars M, Haustant M, Klezovich-Bénard M, Paget C, Trottein F, Goossens PL, Tournier JN.

J Immunol. 2016 Oct 15;197(8):3225-3232. Epub 2016 Sep 7.


Proteolytically Stable Foldamer Mimics of Host-Defense Peptides with Protective Activities in a Murine Model of Bacterial Infection.

Teyssières E, Corre JP, Antunes S, Rougeot C, Dugave C, Jouvion G, Claudon P, Mikaty G, Douat C, Goossens PL, Guichard G.

J Med Chem. 2016 Sep 22;59(18):8221-32. doi: 10.1021/acs.jmedchem.6b00144. Epub 2016 Sep 9.


In vivo dynamics of active edema and lethal factors during anthrax.

Rougeaux C, Becher F, Ezan E, Tournier JN, Goossens PL.

Sci Rep. 2016 Mar 21;6:23346. doi: 10.1038/srep23346. Erratum in: Sci Rep. 2017 Feb 13;7:39579.


Physical Sequestration of Bacillus anthracis in the Pulmonary Capillaries in Terminal Infection.

Jouvion G, Corre JP, Khun H, Moya-Nilges M, Roux P, Latroche C, Tournier JN, Huerre M, Chrétien F, Goossens PL.

J Infect Dis. 2016 Jul 15;214(2):281-7. doi: 10.1093/infdis/jiw098. Epub 2016 Mar 14.


Crossing of the epithelial barriers by Bacillus anthracis: the Known and the Unknown.

Goossens PL, Tournier JN.

Front Microbiol. 2015 Oct 9;6:1122. doi: 10.3389/fmicb.2015.01122. eCollection 2015. Review.


Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.

Trescos Y, Tessier E, Rougeaux C, Goossens PL, Tournier JN.

Infect Immun. 2015 Aug;83(8):3114-25. doi: 10.1128/IAI.00479-15. Epub 2015 May 26.


Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.

Brézillon C, Haustant M, Dupke S, Corre JP, Lander A, Franz T, Monot M, Couture-Tosi E, Jouvion G, Leendertz FH, Grunow R, Mock ME, Klee SR, Goossens PL.

PLoS Negl Trop Dis. 2015 Apr 1;9(4):e0003455. doi: 10.1371/journal.pntd.0003455. eCollection 2015 Apr. Erratum in: PLoS Negl Trop Dis. 2015 Apr;9(4):e0003746.


Identification and validation of specific markers of Bacillus anthracis spores by proteomics and genomics approaches.

Chenau J, Fenaille F, Caro V, Haustant M, Diancourt L, Klee SR, Junot C, Ezan E, Goossens PL, Becher F.

Mol Cell Proteomics. 2014 Mar;13(3):716-32. doi: 10.1074/mcp.M113.032946. Epub 2013 Dec 29.


In vivo germination of Bacillus anthracis spores during murine cutaneous infection.

Corre JP, Piris-Gimenez A, Moya-Nilges M, Jouvion G, Fouet A, Glomski IJ, Mock M, Sirard JC, Goossens PL.

J Infect Dis. 2013 Feb 1;207(3):450-7. doi: 10.1093/infdis/jis686. Epub 2012 Nov 12.


Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection.

Candela T, Dumetz F, Tosi-Couture E, Mock M, Goossens PL, Fouet A.

Vaccine. 2012 Dec 17;31(1):171-5. doi: 10.1016/j.vaccine.2012.10.071. Epub 2012 Nov 1.


Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins.

Klezovich-Bénard M, Corre JP, Jusforgues-Saklani H, Fiole D, Burjek N, Tournier JN, Goossens PL.

PLoS Pathog. 2012 Jan;8(1):e1002481. doi: 10.1371/journal.ppat.1002481. Epub 2012 Jan 12.


cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization.

Maddugoda MP, Stefani C, Gonzalez-Rodriguez D, Saarikangas J, Torrino S, Janel S, Munro P, Doye A, Prodon F, Aurrand-Lions M, Goossens PL, Lafont F, Bassereau P, Lappalainen P, Brochard F, Lemichez E.

Cell Host Microbe. 2011 Nov 17;10(5):464-74. doi: 10.1016/j.chom.2011.09.014.


Sensitive detection of Bacillus anthracis spores by immunocapture and liquid chromatography-tandem mass spectrometry.

Chenau J, Fenaille F, Ezan E, Morel N, Lamourette P, Goossens PL, Becher F.

Anal Chem. 2011 Nov 15;83(22):8675-82. doi: 10.1021/ac2020992. Epub 2011 Oct 18.


Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax.

Dumetz F, Jouvion G, Khun H, Glomski IJ, Corre JP, Rougeaux C, Tang WJ, Mock M, Huerre M, Goossens PL.

Am J Pathol. 2011 Jun;178(6):2523-35. doi: 10.1016/j.ajpath.2011.02.027.


Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host.

Wu Y, Raymond B, Goossens PL, Njamkepo E, Guiso N, Paya M, Touqui L.

Biochimie. 2010 Jun;92(6):583-7. doi: 10.1016/j.biochi.2010.01.024. Epub 2010 Feb 6. Review.


Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation.

Raymond B, Ravaux L, Mémet S, Wu Y, Sturny-Leclère A, Leduc D, Denoyelle C, Goossens PL, Payá M, Raymondjean M, Touqui L.

Biochem Pharmacol. 2010 Apr 15;79(8):1149-55. doi: 10.1016/j.bcp.2009.11.023. Epub 2009 Dec 4.


Encapsulated Bacillus anthracis interacts closely with liver endothelium.

Piris-Gimenez A, Corre JP, Jouvion G, Candela T, Khun H, Goossens PL.

J Infect Dis. 2009 Nov 1;200(9):1381-9. doi: 10.1086/644506.


Animal models of human anthrax: the Quest for the Holy Grail.

Goossens PL.

Mol Aspects Med. 2009 Dec;30(6):467-80. doi: 10.1016/j.mam.2009.07.005. Epub 2009 Aug 7. Review.


Femtomolar detection of the anthrax edema factor in human and animal plasma.

Duriez E, Goossens PL, Becher F, Ezan E.

Anal Chem. 2009 Jul 15;81(14):5935-41. doi: 10.1021/ac900827s.


Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification.

Raymond B, Batsche E, Boutillon F, Wu YZ, Leduc D, Balloy V, Raoust E, Muchardt C, Goossens PL, Touqui L.

PLoS Pathog. 2009 Apr;5(4):e1000359. doi: 10.1371/journal.ppat.1000359. Epub 2009 Apr 3.


Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

Infect Immun. 2009 Mar;77(3):1197-207. doi: 10.1128/IAI.01217-08. Epub 2008 Dec 29.


Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting.

Glomski IJ, Dumetz F, Jouvion G, Huerre MR, Mock M, Goossens PL.

Microbes Infect. 2008 Oct;10(12-13):1398-404. doi: 10.1016/j.micinf.2008.07.042. Epub 2008 Aug 13.


Bacillus anthracis: balancing innocent research with dual-use potential.

Hudson MJ, Beyer W, Böhm R, Fasanella A, Garofolo G, Golinski R, Goossens PL, Hahn U, Hallis B, King A, Mock M, Montecucco C, Ozin A, Tonello F, Kaufmann SH.

Int J Med Microbiol. 2008 Jul;298(5-6):345-64. doi: 10.1016/j.ijmm.2007.09.007. Epub 2008 Mar 28. Review.


Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.

Raymond B, Leduc D, Ravaux L, Le Goffic R, Candela T, Raymondjean M, Goossens PL, Touqui L.

PLoS Pathog. 2007 Dec;3(12):e187.


Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.

Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL.

PLoS Pathog. 2007 Jun;3(6):e76.


Of spore opsonization and passive protection against anthrax.

Goossens PL, Sylvestre P, Mock M.

Microbiology. 2007 Feb;153(Pt 2):301-2; discussion 302-4. No abstract available.


Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores.

Glomski IJ, Fritz JH, Keppler SJ, Balloy V, Chignard M, Mock M, Goossens PL.

Cell Microbiol. 2007 Feb;9(2):502-13. Epub 2006 Sep 18.


[Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?].

Tournier JN, Quesnel-Hellmann A, Cleret A, Mathieu J, Goossens PL, Mock M, Vidal DR.

Bull Acad Natl Med. 2006 Jan;190(1):155-63; discussion 163-7. French.


In vivo protective role of human group IIa phospholipase A2 against experimental anthrax.

Piris-Gimenez A, Paya M, Lambeau G, Chignard M, Mock M, Touqui L, Goossens PL.

J Immunol. 2005 Nov 15;175(10):6786-91.


Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells.

Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, Mock M, Vidal DR, Goossens PL.

J Immunol. 2005 Apr 15;174(8):4934-41.


High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin.

Gimenez AP, Wu YZ, Paya M, Delclaux C, Touqui L, Goossens PL.

J Immunol. 2004 Jul 1;173(1):521-30.


Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection.

Soussi N, Saklani-Jusforgues H, Colle JH, Milon G, Glaichenhaus N, Goossens PL.

Vaccine. 2002 Jun 21;20(21-22):2702-12.


Early translocation of acid-adapted Listeria monocytogenes during enteric infection in TNF/LTalpha-/- mice.

Fontan E, Saklani-Jusforgues H, Goossens PL.

FEMS Microbiol Lett. 2001 Dec 18;205(2):179-83.


Characterisation of a Listeria monocytogenes mutant deficient in D-arabitol fermentation.

Saklani-Jusforgues H, Fontan E, Goossens PL.

Res Microbiol. 2001 Mar;152(2):175-7.


Effect of acid-adaptation on Listeria monocytogenes survival and translocation in a murine intragastric infection model.

Saklani-Jusforgues H, Fontan E, Goossens PL.

FEMS Microbiol Lett. 2000 Dec 1;193(1):155-9.


Identification of four new members of the internalin multigene family of Listeria monocytogenes EGD.

Dramsi S, Dehoux P, Lebrun M, Goossens PL, Cossart P.

Infect Immun. 1997 May;65(5):1615-25.


Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response.

Goossens PL, Montixi C, Saron MF, Rodriguez M, Zavala F, Milon G.

Biologicals. 1995 Jun;23(2):135-43. Review.


Supplemental Content

Loading ...
Support Center